Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04162847 · ClinicalTrials.gov registry record · NA
Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations
A NA study of Anxiety Disorders and Depressive Disorder, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 6,205
- Enrollment target
- 4
- Study locations
NCT04162847: Completed NA study of Anxiety Disorders and Depressive Disorder, sponsored by Washington University School of Medicine.
NCT04162847 is a NA study of Anxiety Disorders and Depressive Disorder that has completed, run by Washington University School of Medicine. The registered enrollment target is 6,205 participants, above the 1,066-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (482% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04162847, a NA study of Anxiety Disorders and Depressive Disorder, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,205 participants
- Enrollment target
- 4
- Study locations
Study Summary
The prevalence of mental health problems among college populations has risen steadily in recent decades, with one third of today's students struggling with anxiety, depression, or an eating disorder (ED). Yet, only 20-40% of college students with mental disorders receive treatment. Inadequacies in mental health care delivery result in prolonged illness, disease progression, poorer prognosis, and greater likelihood of relapse, highlighting the need for a new approach for detecting mental health problems and engaging college students in services. The investigators have developed a transdiagnostic, low-cost mobile health targeted prevention and intervention platform that uses population-level screening for engaging college students in tailored services that address common mental health problems. This care delivery system represents an ideal model given its use of evidence-based mobile programs, a transdiagnostic approach that addresses comorbid mental health issues, and personalized screening and intervention to increase service uptake, enhance engagement, and improve outcomes. Further, this service delivery model harnesses the expertise of an interdisciplinary team of behavioral scientists, college student mental health scholars, technology researchers, and health economists. This work bridges the study team's collective leadership over the past 25 years in successfully implementing a population-based screening program in more than 160 colleges and demonstrating the effectiveness of Internet-based programs for targeted prevention and intervention for anxiety, depression, and EDs. Through this study, Investigators will test the impact of this mobile mental health platform for service delivery in a large-scale trial across a diverse range of U.S. colleges. Students who screen positive or at high-risk for clinical anxiety, depression, or EDs (excluding anorexia nervosa, for which more intensive medical monitoring is warranted) and who are not currently engaged in mental
Primary Outcome
Effectiveness of the mobile mental health platform, compared to usual care, in reducing or preventing the number of individuals with mental health disorders (i.e., a positive screen for at least one of anxiety, depression, or eating disorder as the outcome reflecting a "clinical case"), assessed at 6 months and 2 years, with a primary endpoint of 2 years. Clinical case status will be determined using the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) for generalized anxiety disorder, S
Conditions Studied
Interventions
- DEVICE SilverCloud Health Intervention
Study Locations (4)
California
- Palo Alto University - Palo Alto
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University School of Medicine - St Louis
Pennsylvania
- Pennsylvania State University - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,205 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04162847 record still lists
NCT04162847 is an interventional study that assigns participants to a tested intervention. Its 6,205 participants enrollment target places it among the larger protocols in the corpus, above the 1,066-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (482% higher).
The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which SilverCloud Health Intervention is the first listed.
NCT04162847 reports a single indexed study location in California, Michigan, Missouri.
Frequently Asked Questions
What is clinical trial NCT04162847 about?
NCT04162847 is a clinical study titled "Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations". The prevalence of mental health problems among college populations has risen steadily in recent decades, with one third of today's students struggling with anxiety, depression, or an eating disorder (ED). Yet, only 20-40% of college students with mental disorders receive treatment. Inadequacies in m...
What is the current status of trial NCT04162847?
This trial is currently completed. It is a NA study. The enrollment target is 6,205 participants. The study started on 2019-10-07. Estimated completion is 2023-12-31.
What conditions does trial NCT04162847 study?
This clinical trial studies the following conditions: Anxiety Disorders, Depressive Disorder, Eating Disorders.
What interventions are being tested in trial NCT04162847?
The interventions under investigation include: SilverCloud Health Intervention (DEVICE).
Who is sponsoring clinical trial NCT04162847?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04162847 being conducted?
This trial has 4 study locations across California, Michigan, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04162847's enrollment target sits among peer trials
6,205 3rd of 84 higher than 82 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07049861 · 6,200 participants · NA
Advancing Biopsychosocial Care Training Initiative
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
- NCT05440851 · 6,250 participants · NA
Platform of Randomized Adaptive Clinical Trials in Critical Illness
- NCT06566170 · 6,250 participants
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI